By acting on both the homeostatic (hunger-driven) and hedonic (pleasure-driven) aspects of eating, GLP-1 effectively recalibrates the brains perception of food
Because of this, certain medications that act on metabolic systems, including GLP-1 receptor agonists, are being included in the conversation surrounding management of menopause symptoms
Individuals with a history of pancreatitis, medullary thyroid cancer, or severe gastrointestinal disorders should consult with their provider about potential risks
Food stays in the stomach longer, which can cause bloating, fullness, or discomfort if meals are too large or too rich
Clinical oversight is essential
The injection site information in this article reflects general clinical practices for subcutaneous GLP-1 medications